Moderna to launch trials of new booster vaccine that targets South African Covid variant
Moderna has become the first vaccine maker to develop a jab that targets the South African coronavirus variant. The Boston-based biotech has already shipped the raw materials to the US National Institutes of Health, which helped the firm study its first jab, to start human trials. Dr Anthony Fauci, the US’ top Covid expert, and his … Read more